𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phenotype 2 of deoxyribonuclease I may be Used as a risk factor for gastric carcinoma

✍ Scribed by Souichi Tsutsumi; Takayuki Asao; Yukio Nagamachi; Tamiko Nakajima; Toshihiro Yasuda; Koichiro Kishi


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
76 KB
Volume
82
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Background:

Human deoxyribonuclease i (dnase i) (ec3.1.21.1) is one of the candidate nucleases that acts in mammalian cells during apoptosis. genetic polymorphism of dnase i has been classified into 15 phenotypes controlled by 5 autosomal codominant alleles. the purpose of this study was to determine whether dnase i polymorphism is closely related to the incidence of gastric carcinoma.

Methods:

The phenotype distribution was examined using urine samples obtained from unrelated japanese patients with gastric carcinoma (n = 97) and benign gastric diseases (n = 76). phenotyping was performed using isoelectric focusing electrophoresis in thin polyacrylamide gel and immunoblotting with an antihuman dnase i antibody.

Results:

A close statistical association was found between patients with gastric carcinoma and a high frequency of dnase i phenotype 2. however, there was no significant difference in the phenotype distribution between the group of patients with benign gastric diseases and the controls.

Conclusions:

The findings of the current study suggest that dnase i phenotype 2 may be a marker for gastric carcinoma. therefore, compared with other phenotypes, dnase i phenotype 2 may have potential for identifying patients who are at risk of harboring or developing gastric carcinoma.


πŸ“œ SIMILAR VOLUMES


Serum insulin-like growth factor I evalu
✍ Gherardo Mazziotti; Francesca Sorvillo; Filomena Morisco; Antonella Carbone; Mar πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 108 KB πŸ‘ 3 views

## Background: Although experimental studies have demonstrated an important role of insulin-like growth factor i (igf-i) in hepatocarcinogenesis, the clinical data about igf-i in patients with hepatocellular carcinoma (hcc) are scarce and controversial. to the authors' knowledge, this is the first